Azione NUMD NU-MED PLUS, INC.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Nu-Med Plus, Inc.

Azioni

NUMD

US67021R1041

Mercato chiuso - OTC Markets
Altri mercati azionari
 21:51:17 03/05/2024 		Variaz. 5gg Var. 1 gen.
0,085 USD +27,06% Grafico intraday di Nu-Med Plus, Inc. +27,82% +109,88%
28/04 Nu-Med Plus, Inc. (OTCPK:NUMD) ha completato l'acquisizione di Your Space, Inc. da William R. Colvin, Robert Papri, Arthur Hood, William Hayde e Dan Bittner. CI
26/03 Nu-Med Plus, Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Nu Med Plus : Material Agreement - Form 8-K
Nu-Med Plus, Inc. completed the acquisition of Your Space, Inc. from William R. Colvin, Robert Papri, Arthur Hood, William Hayde, and Dan Bittner.
Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nu-Med Plus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Nu-Med Plus, Inc. entered into a letter of intent to acquire Your Space, Inc. from William R. Colvin, Robert Papri, Arthur Hood, William Hayde, and Dan Bittner.
Nu-Med Plus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
NU-MED PLUS, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
NU-MED PLUS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND (form 10-K)
Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Nu-Med Plus, Inc. Auditor Raises 'Going Concern' Doubt
Nu Med Plus : Change in Certifying Accountants - Form 8-K
NU-MED PLUS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
NU-MED PLUS, INC. Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K/A)
NU-MED PLUS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
NU-MED PLUS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Nu-Med Plus, Inc. announced that it has received $0.1 million in funding from Your Space, Inc
NU-MED PLUS, INC. : Change in Directors or Principal Officers (form 8-K)
Nu-Med Plus, Inc. Appoints Jeffrey L. Robins to the Board of Director
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione NUMD
  4. Notizie Nu-Med Plus, Inc.
  5. Altre lingue